Vitality Watch

Dossier pubmed observational 05-nov-2026
Human cohort, case-control, or epidemiological association

Resistant hypertension and accelerated vascular aging: evidence for PTEN-AKT-associated cellular senescence.

Key claim: Resistant hypertension in older and obese individuals is characterized by accelerated vascular aging driven by PTEN downregulation and AKT-dependent endothelial cellular senescence.

Abstract

Resistant hypertension (RH) is increasingly linked to accelerated vascular aging and is particularly prevalent among older and obese individuals. Cellular senescence has emerged as a potential driver of vascular aging, but its contribution to RH remains unclear. We examined age and body mass index (BMI) in the WalkByLab cohort and assessed whether RH was associated with vascular features consistent with accelerated aging. Obesity-related transcriptomic datasets were integrated with a curated senescence-associated gene set to identify candidate regulators, followed by validation in an independent RH dataset, PBMCs, and human endothelial cells. An exploratory clinical-molecular nomogram was also developed. BMI and age increased progressively from normotension to RH. RH was characterized by reduced flow-mediated dilation, increased pulse wave index, and unchanged ankle-brachial index, consistent with endothelial dysfunction and arterial stiffness. Transcriptomic analyses identified enrichment of inflammatory, PI3K-AKT, and senescence-associated pathways. In PBMCs from RH patients, PTEN expression was reduced, AKT phosphorylation was increased, and p16/p21 levels were elevated, indicating a systemic senescence-associated molecular profile. In human endothelial cells, exposure to obese serum or pharmacological PTEN inhibition induced AKT activation and cellular senescence, whereas AKT inhibition attenuated these effects. Together, transcriptomic, clinical, and experimental findings indicate that RH is associated with vascular and molecular features consistent with accelerated vascular aging. Human data indicate a systemic senescence-associated molecular profile, whereas endothelial cell experiments support endothelial senescence as a mechanistically relevant cellular component. PTEN-AKT-associated cellular senescence may represent one mechanistically relevant component linking obesity to vascular dysfunction in RH.

Why this matters

The human association places resistant hypertension within the vascular-aging and endothelial-senescence picture, extending these mechanisms into a clinically defined treatment-resistant population [human-observational]. The accompanying cell experiments implicate PTEN downregulation and AKT-dependent senescence [mechanism-plausible], but do not establish that this pathway drives treatment resistance in patients or that targeting it improves blood-pressure control.

Source

Link

Briefing card

Resistant hypertension and accelerated vascular aging: evidence for PTEN-AKT-associated cellular senescence.
Stage: observational · pubmed · 05-nov-2026

If you have obesity and resistant hypertension, this finding concerns vascular-aging markers, not evidence that a diet or fasting regimen reverses them.

Resistant hypertension in older and obese individuals is characterized by accelerated vascular aging driven by PTEN downregulation and AKT-dependent endothelial cellular senescence.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1007/s11357-026-02627-8

build build 880 · 2bcef25 · 2026-11-18